Sunovion (United States)
In research, Sunovion (United States) stands highest in Medicine (#14,491 of 17,978 worldwide) and Health Sciences (#17,102 of 20,462 worldwide), over all time.
- World rank, all time
- #21,588 of 42,892
- Rank in United States
- #4,666 of 8,685
- Research works
- 372 ▲ 23% vs 2013–17
- Citations
- 8.3k 22.3 per fractional work
- Top-10% rate
- 10.0% record average 16.5%
- Open access
- 31% world 28%
What is Sunovion (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #14,491 of 17,978 | 13.6% | 154 | |
| Health SciencesDomain | #17,102 of 20,462 | 13.7% | 160 |
Each strip is that field’s whole ranked pool, with the notch where Sunovion (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.7×. Every wedge is a field page.
- Neuroscience 4.7×
- Pharmacology, Toxicology and Pharmaceutics 4.7×
- Mathematics 4.3×
- Psychology 3.3×
- Medicine 2.7×
- Health Professions 1.7×
- Economics, Econometrics and Finance 1.6×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Nursing 0.9×
- Chemistry 0.5×
- Arts and Humanities 0.4×
- Decision Sciences 0.4×
- Computer Science 0.2×
- Immunology and Microbiology 0.2×
- Materials Science 0.2×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Engineering 0.0×
Who are the top researchers at Sunovion (United States)?
Ranked on the composite score, Stephen A. Wald, John Karafilidis and Surendra P. Singh lead among researchers whose main affiliation is Sunovion (United States).
- 1 Stephen A. Wald United States · #991,177 worldwide 81 citations · 16 works
- 2 John Karafilidis United States · #1,351,215 worldwide 3 citations · 18 works
- 3 Surendra P. Singh United States · #1,526,893 worldwide 27 citations · 21 works
Which keywords describe research at Sunovion (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Genetics, Metabolic Syndrome, Inflammation, Neurobiology, Antipsychotic Drugs, Neurocognitive Deficits, Parkinson's Disease and Prevalence.
- Antiepileptic Drugs
- Bipolar Spectrum Disorder
- Quality of Life
- Epilepsy
- a-Synuclein
- Dopaminergic Neurons
- Cognitive Function
- Mitochondrial Dysfunction
- Neurological Disorders
- Oxidative Stress
- Neurocognitive Deficits
- Antipsychotic Drugs
- Genetics
- Inflammation
- Metabolic Syndrome
- Neurobiology
- Parkinson's Disease
- Prevalence
- Depression
- Neurodegeneration
- Diagnostic Criteria
- Neuroimaging
- Epidemiology
- Meta-Analysis
- Treatment
- Treatment Guidelines
- Biomarkers
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 27 words, with their numbers
- Inflammation3▲ 5.8×11 topics
- Genetics3▲ 16×5 topics
- Metabolic Syndrome3▲ 14×4 topics
- Antipsychotic Drugs3▲ 257×1 topic
- Neurobiology3▲ 39×3 topics
- Neurocognitive Deficits3▲ 257×1 topic
- Parkinson's Disease2▲ 36×4 topics
- Oxidative Stress2▲ 5.0×4 topics
- Prevalence2▲ 20×4 topics
- Neurological Disorders2▲ 13×7 topics
- Depression2▲ 7.7×6 topics
- Mitochondrial Dysfunction2▲ 23×3 topics
- Neurodegeneration2▲ 22×2 topics
- Cognitive Function2▲ 35×2 topics
- Diagnostic Criteria2▲ 28×2 topics
- Dopaminergic Neurons2▲ 95×1 topic
- Neuroimaging2▲ 23×3 topics
- a-Synuclein2▲ 117×1 topic
- Epidemiology2▲ 1.42×9 topics
- Epilepsy1▲ 45×2 topics
- Meta-Analysis1▲ 8.7×3 topics
- Quality of Life1▲ 3.3×4 topics
- Treatment1▲ 4.0×3 topics
- Bipolar Spectrum Disorder1▲ 200×1 topic
- Treatment Guidelines1▲ 21×1 topic
- Antiepileptic Drugs1▲ 56×2 topics
- Biomarkers1▲ 6.1×2 topics
Which research topics does Sunovion (United States) publish most on?
By volume in 2022–2025: Schizophrenia research and treatment, Parkinson's Disease Mechanisms and Treatments, Bipolar Disorder and Treatment and Statistical Methods in Clinical Trials.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Schizophrenia research and treatment Psychiatry and Mental health 3 works
- 2 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
- 3 Bipolar Disorder and Treatment Psychiatry and Mental health 1 works
- 4 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 5 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 1 works
- 6 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works
- 7 Receptor Mechanisms and Signaling Molecular Biology 1 works
- 8 Epilepsy research and treatment Psychiatry and Mental health 1 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 10 Neurological disorders and treatments Neurology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sunovion (United States)'s research output changed?
Output in 2018–2022 was 23% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Marlborough
- Boston Scientific (United States)
- Sumitomo Dainippon Pharma (United States)
- Hologic (United States)
- Hottinger Baldwin Messtechnik (United States)
- Advanced Cell Technology (United States)
- Phio Pharmaceuticals (United States)
- CardioFocus (United States)
- Verax Biomedical (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.